Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by TriaGen Wealth Management LLC

TriaGen Wealth Management LLC lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 4,286 shares of the medical equipment provider’s stock after selling 103 shares during the period. TriaGen Wealth Management LLC’s holdings in Intuitive Surgical were worth $2,237,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Bennett Selby Investments LP lifted its position in Intuitive Surgical by 3.9% during the fourth quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock worth $234,000 after buying an additional 17 shares during the period. LVW Advisors LLC lifted its position in Intuitive Surgical by 1.3% during the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock worth $756,000 after buying an additional 19 shares during the period. Wesbanco Bank Inc. lifted its position in Intuitive Surgical by 1.6% during the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock worth $635,000 after buying an additional 19 shares during the period. Hazlett Burt & Watson Inc. lifted its position in Intuitive Surgical by 5.8% during the third quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock worth $177,000 after buying an additional 20 shares during the period. Finally, Mitchell Mcleod Pugh & Williams Inc. raised its holdings in shares of Intuitive Surgical by 4.1% in the 3rd quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider’s stock worth $247,000 after purchasing an additional 20 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity

In related news, insider Jamie Samath sold 22,903 shares of the business’s stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the completion of the transaction, the insider now owns 8,757 shares in the company, valued at $4,597,425. The trade was a 72.34 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now owns 12,275 shares of the company’s stock, valued at $6,955,015. This represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 28,843 shares of company stock worth $15,357,560. 0.90% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of research firms have recently commented on ISRG. UBS Group raised their price objective on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a report on Monday, January 27th. BTIG Research raised their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and raised their price objective for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. Robert W. Baird raised their price objective on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a report on Thursday, October 17th. Finally, Truist Financial raised their price objective on Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a report on Friday, January 24th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Trading Down 1.4 %

Shares of ISRG opened at $571.88 on Friday. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The firm has a market cap of $203.69 billion, a price-to-earnings ratio of 89.22, a PEG ratio of 5.52 and a beta of 1.39. The stock has a 50 day moving average of $549.92 and a 200-day moving average of $508.00.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.